Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus vs Prednisone in Standard-Risk Acute GVHD
NCT02806947Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Medical College of Wisconsin. Started Oct 2016; status: completed.
02
Drugs
sirolimus
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT02806947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806947.